Date | Title | Description | Source |
23.01.2024 | Ahead of Medicare drug price reform, pharma’s drug pricing h... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
14.11.2023 | Autobahn Labs Announces Key Licensing Milestones in Alliance... | I’m thrilled to see our early partnerships bearing fruit. The two startups, in which we have already... | einpresswi... |
08.08.2023 | Autobahn Labs Appoints Chief Executive Officer | Brendan O'Leary - CEO, Autobahn Labs
Experienced Life Sciences Executive and Venture Capitalist Dr. ... | einpresswi... |
09.05.2023 | Autobahn Labs Announces Strategic Collaboration with the Sal... | New Collaboration Adds to Autobahn Labs’ Transformative Biotech Incubator Model in California and th... | einpresswi... |
07.04.2023 | Cyber Attack on Evotec | HAMBURG, GERMANY / ACCESSWIRE / April 7, 2023 / Evotec SE ((Frankfurt Stock Exchange: EVT, MDAX/TecD... | einpresswi... |
13.02.2023 | Hamburg-based Evotec bags €150M loan from EIB to accelerate ... | Hamburg-based Evotec, a life sciences company, announced on Friday, February 10, that it has raised ... | siliconcan... |
10.02.2023 | Evotec Receives € 150 m Loan from European Investment Bank | FINANCING FOR 3 CORE PILLARS: R&D ACTIVITIES, EQUITY INVESTMENTS AND CONSTRUCTION OF MANUFACTURI... | accesswire... |
10.02.2023 | Evotec Receives € 150 m Loan from European Investment Bank | FINANCING FOR 3 CORE PILLARS: R&D ACTIVITIES, EQUITY INVESTMENTS AND CONSTRUCTION OF MANUFACTURI... | einpresswi... |
26.01.2023 | Evotec Announces Agreement with Janssen to Develop Immune-Ba... | STRATEGIC PARTNERSHIP LEVERAGES EVOTEC'S EXPERTISE & INTEGRATED PLATFORM FOR DISCOVERY AND DEVEL... | einpresswi... |
03.11.2022 | Evotec Completes Acquisition of Central Glass Germany | AS EVOTEC DRUG SUBSTANCE (GERMANY) GMBH, THE ACQUISITION STRENGTHENS EVOTEC'S CLINICAL AND COMMERCIA... | accesswire... |
25.08.2022 | Evotec Expands Clinical and Commercial Drug Substance Manufa... | EXPANSION OF CGMP DRUG SUBSTANCE MANUFACTURING PLATFORM WILL CREATE A CLEAR PATH TO THE MARKET FOR R... | accesswire... |
22.06.2022 | Evotec SE Reports Results of Annual General Meeting 2022 | ALL AGENDA ITEMS ADOPTED WITH THE REQUIRED MAJORITY
CAMILLA MACAPILI LANGUILLE ELECTED AS NEW MEMBER... | accesswire... |
14.06.2022 | Evotec Enters a Drug Discovery Collaboration with Janssen | STRATEGIC PARTNERSHIP LEVERAGES EVOTEC'S PROPRIETARY PLATFORM CAPABILITIES IN THE FIELD OF PROTEIN H... | accesswire... |
10.05.2022 | Evotec and Bristol Myers Squibb Extend and Expand Strategic ... | 8-YEAR EXTENSION AND EXPANSION OF COLLABORATION TO DEVELOP PIPELINE OF MOLECULAR GLUE DEGRADERS
COLL... | accesswire... |
10.05.2022 | Evotec and Bristol Myers Squibb Extend and Expand Strategic ... | HAMBURG, GERMANY / ACCESSWIRE / May 10, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX... | accesswire... |
04.05.2022 | Evotec SE to Announce Results for the First Quarter 2022 on ... | HAMBURG, GERMANY / ACCESSWIRE / May 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX,... | accesswire... |
03.05.2022 | Tubulis Closes €60 Million Series B Financing to Accelerate ... | May 3, 2022 | htgf.de/en... |
08.04.2022 | Evotec Achieves Programme Designation in Neuroscience Collab... | THE PROGRAMME DESIGNATION IS BASED ON AN ANTISENSE-BASED APPROACH WHICH TRIGGERS A US$ 16 M PAYMENT ... | accesswire... |
31.01.2022 | Evotec SE: Preliminary announcement of the publication of qu... | DGAP Preliminary announcement financial reports: Evotec SE / Preliminary announcement on the disclos... | marketscre... |
31.01.2022 | Evotec SE: Preliminary announcement of the publication of fi... | DGAP Preliminary announcement financial reports: Evotec SE / Preliminary announcement on the disclos... | marketscre... |
18.01.2022 | Evotec and Lilly enter into drug discovery collaboration in ... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec and Lilly enter into drug discovery collabo... | marketscre... |
11.01.2022 | Evotec expands neuroscience collaboration with Bristol Myers... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec expands neuroscience collaboration with Bri... | marketscre... |
11.01.2022 | Evotec : expands neuroscience collaboration with Bristol Mye... | NEWS RELEASE, 11 JANUARY 2022
EVOTEC EXPANDS NEUROSCIENCE COLLABORATION WITH BRISTOL MYERS SQUIBB TO... | marketscre... |
04.01.2022 | Evotec receives EUR 7.5 m grant for development of COVID-19 ... | Evotec SE (Frankfurt Stock Exchange - EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced t... | marketscre... |
03.01.2022 | Evotec receives ? 7.5 m grant for development of COVID-19 th... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec receives ? 7.5 m grant for development of C... | marketscre... |
03.01.2022 | Evotec : receives 7.5 m grant for development of COVID-19 ... | NEWS RELEASE, 03 JANUARY 2022
EVOTEC RECEIVES € 7.5 M GRANT FOR DEVELOPMENT OF COVID-19 THERAPEUTIC
... | marketscre... |
16.12.2021 | Evotec receives US$ 18 m grant for women's health | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec receives US$ 18 m grant for women's health
... | marketscre... |
16.12.2021 | Evotec : receives US$ 18 m grant for women's health | NEWS RELEASE, 16 DECEMBER 2021
EVOTEC RECEIVES US$ 18 M GRANT FOR WOMEN'S HEALTH
GRANT WILL SUPPORT ... | marketscre... |
16.11.2021 | Evotec : announces the exercise of the Greenshoe option | NEWS RELEASE, 16 NOVEMBER 2021
EVOTEC ANNOUNCES THE EXERCISE OF THE GREENSHOE OPTION
Hamburg, German... | marketscre... |
11.11.2021 | Evotec SE reports results for the first nine months 2021 and... | DGAP-News: Evotec SE / Key word(s): 9 Month figures
Evotec SE reports results for the first nine mon... | marketscre... |
11.11.2021 | Evotec SE reports results for the first nine months 2021 and... | STRONG OPERATIONAL PERFORMANCE LEADS TO SIGNIFICANT REVENUE GROWTH
CO-OWNED PIPELINE GAINING MOMENTU... | marketscre... |
10.11.2021 | Evotec reaches programme designations in neuroscience collab... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec reaches programme designations in neuroscie... | marketscre... |
10.11.2021 | Evotec reaches programme designations in neuroscience collab... | NEWS RELEASE, 10 NOVEMBER 2021
EVOTEC REACHES PROGRAMME DESIGNATIONS IN NEUROSCIENCE COLLABORATION W... | marketscre... |
09.11.2021 | Evotec SE announces closing of public offering | NEWS RELEASE, 09 NOVEMBER 2021
EVOTEC ANNOUNCES CLOSING OF PUBLIC OFFERING
Hamburg, Germany, 09 Nove... | marketscre... |
04.11.2021 | Evotec SE Announces Placement of its Public Offering of Amer... | Evotec SE Announces Placement of its Public Offering of American Depositary Shares
Hamburg, Germany,... | marketscre... |
27.10.2021 | Evotec announces first funded projects of translational BRID... | Evotec announces first funded projects of translational BRIDGE beLAB1407 in collaboration with Brist... | marketscre... |
27.10.2021 | Evotec SE: Translational BRIDGE beLAB2122 in collaboration w... | Evotec SE: Translational BRIDGE beLAB2122 in collaboration with Bristol Myers Squibb identifies firs... | marketscre... |
26.10.2021 | German biotech Evotec seeks over $9 bln valuation in U.S. IP... | Oct 26 (Reuters) - German biotech firm Evotec SE said on Tuesday it would seek a valuation of about ... | marketscre... |
26.10.2021 | German drug developer Evotec seeks over $9 bln valuation in ... | Oct 26 (Reuters) - Frankfurt-listed drug discovery and development company Evotec SE said on Tuesday... | marketscre... |
26.10.2021 | Evotec SE announces launch of public offering of American De... | Evotec SE announces launch of public offering of American Depositary Shares
Hamburg, Germany, 26 Oct... | marketscre... |
21.10.2021 | Growing together with partners | | startuptic... |
11.10.2021 | Strong Pipeline of Drugs for Treatment Of Psychotic Disorder... | FinancialNewsMedia.com News Commentary
PALM BEACH, Fla., Oct. 11, 2021 /PRNewswire/ -- There is a hi... | salamancap... |
11.10.2021 | Strong Pipeline of Drugs for Treatment Of Psychotic Disorder... | PALM BEACH, Fla., Oct. 11, 2021 /PRNewswire/ -- There is a high demand for more advanced products fo... | salamancap... |
08.10.2021 | Evotec : expands neuroscience collaboration with Bristol Mye... | Evotec expands neuroscience collaboration with Bristol Myers Squibb to include novel cell type
INCLU... | marketscre... |
08.10.2021 | Evotec : expands neuroscience collaboration with Bristol Mye... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec expands neuroscience collaboration with Bri... | marketscre... |
04.09.2021 | Abrupt FDA exits spark concern; Unpacking key concepts ... | Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want thi... | endpts.com... |
03.09.2021 | Ziopharm finds new CEO after six-month search; CFO transi... | Kevin Boyle
Less than a year removed from a successful activist attack, Ziopharm Oncology a... | endpts.com... |
03.09.2021 | Sister to Juno's liso-cel, JW's relma-cel lands second-ev... | Juno may have stumbled its way to a distant third finish in the CD19 CAR-T race, but its joint ve... | endpts.com... |
03.09.2021 | Bristol Myers licenses for Evotec molecule for $20M; F... | Bristol Myers Squibb has exercised its option with Evotec for EVT8683, a small molecule crea... | endpts.com... |
02.09.2021 | Evotec : announces Bristol Myers Squibb opt-in of EVT8683 as... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec announces Bristol Myers Squibb opt-in of EV... | marketscre... |
02.09.2021 | PRESS RELEASE : Secarna Pharmaceuticals GmbH & Co. KG: S... | DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Miscellaneous Secarna Pharmaceut... | marketscre... |
02.09.2021 | Hot off of a $210M Series B, Umoja breaks ground in Color... | Boulder County, CO, is getting a new manufacturing facility, and it will come from a Seat... | endpts.com... |
02.09.2021 | Evotec : partner Kazia Therapeutics announces full regulator... | Evotec partner Kazia Therapeutics announces full regulatory approval for Phase I study of EVT801
Syd... | marketscre... |
02.09.2021 | Secarna Pharmaceuticals GmbH & Co. KG: Secarna Pharmaceu... | DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Miscellaneous
Secarna Pharmaceut... | marketscre... |
02.09.2021 | Evotec : announces Bristol Myers Squibb opt-in of EVT8683 as... | Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neuro... | marketscre... |
02.09.2021 | Evotec : and Secarna Pharmaceuticals expand strategic partne... | Munich/Martinsried and Hamburg, Germany, 02 September 2021:
Evotec SE (Frankfurt Stock Exchange: EVT... | marketscre... |
31.08.2021 | In a major blow to vaccine efforts, senior FDA leaders ... | A private equity group has joined hands with a sovereign wealth fund out of Singapore to strike a de... | endpts.com... |
31.08.2021 | In a major blow to vaccine efforts, senior FDA leaders ... | A program touted by Novartis CEO Vas Narasimhan as a near-slam dunk has flopped a Phase IIb study, l... | endpts.com... |
31.08.2021 | In a major blow to vaccine efforts, senior FDA leaders ... | Two prominent House committees are digging deeper into the FDA’s cozy relationship with Biogen as it... | endpts.com... |
12.08.2021 | Manufacturing issues hold back distribution of overdose inje... | In April, Pfizer was forced to stop production of the injectable opioid antidote naloxone, after a m... | endpts.com... |
11.08.2021 | Evotec : Just - Evotec Biologics opens J.POD® 1 US in Redmon... | Just - Evotec Biologics opens J.POD® 1 US in Redmond, Washington
J.POD® 1 US PROVIDES UNIQUELY FLEXI... | marketscre... |
11.08.2021 | Evotec : Just - Evotec Biologics opens J.POD 1 US in Redmond... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Just - Evotec Biologics opens J.POD 1 US in Redmon... | marketscre... |
03.08.2021 | Evotec SE: Positive Phase IIb data for investigational P2X3 ... | Evotec SE: Positive Phase IIb data for investigational P2X3 antagonist in patients with refractory c... | marketscre... |
02.08.2021 | Evotec : Announces Confidential Submission of Draft Registra... | Evotec SE Announces Confidential Submission of Draft Registration Statement on Form F-1 with the U.S... | marketscre... |
29.07.2021 | Evotec : spin-off Topas Therapeutics extends Series B, raisi... | Evotec spin-off Topas Therapeutics extends Series B, raising total of € 40 m (~$ 48 m) in this round... | marketscre... |
29.07.2021 | Evotec : spin-off Topas Therapeutics extends Series B, raisi... | Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pi... | marketscre... |
29.07.2021 | Evotec : spin-off Topas Therapeutics extends Series B, raisi... | Evotec spin-off Topas Therapeutics extends Series B, raising total of €40 Million (~$48 Million) in ... | marketscre... |
01.07.2021 | Evotec : creates long-term growth opportunities by initiatin... | Evotec creates long-term growth opportunities by initiating 'Campus Levi-Montalcini' in Verona
EVOTE... | marketscre... |
01.07.2021 | Evotec : creates long-term growth opportunities by initiatin... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec creates long-term growth opportunities by i... | marketscre... |
15.06.2021 | EVOTEC SE
Evotec : launches “PRROTECT”, a pre-competitive i... | Evotec launches 'PRROTECT', a pre-competitive initiative to be better prepared for future pandemics
... | marketscre... |
15.06.2021 | EVOTEC SE
Evotec : launches 'PRROTECT', a pre-competitive i... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec launches 'PRROTECT', a pre-competitive init... | marketscre... |
14.06.2021 | EVOTEC SE
Evotec : partners with CEBINA to launch Danube La... | Vienna, Austria, 14 June 2021:
CEBINA GmbH, Central European Biotech Incubator and Accelerator, toda... | marketscre... |
07.06.2021 | EVOTEC SE
Evotec : Autobahn Labs incubator announces partne... | Autobahn Labs incubator announces partnership with Cold Spring Harbor Laboratory to advance novel sc... | marketscre... |
06.05.2021 | EVOTEC SE
Evotec : launches 'beLAB1407' to accelerate trans... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec launches 'beLAB1407' to accelerate translat... | marketscre... |
04.05.2021 | EVOTEC SE
Evotec : and the GCKD study enter into strategic ... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec and the GCKD study enter into strategic col... | marketscre... |
04.05.2021 | EVOTEC SE
Evotec : and the GCKD study enter into strategic ... | Evotec and the GCKD study enter into strategic collaboration to build a unique molecular patient dat... | marketscre... |
28.04.2021 | SoftBank leads funding that could net up to $525M for Exscie... | With two partnered drugs in the clinic, Exscientia is reeling in up to $525 million to push its own ... | fiercebiot... |
26.04.2021 | EVOTEC SE
Evotec : Bristol Myers Squibb exercises option to... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Bristol Myers Squibb exercises option to extend ta... | marketscre... |
26.04.2021 | EVOTEC SE
Evotec : Bristol Myers Squibb exercises option to... | Bristol Myers Squibb exercises option to extend targeted protein degradation partnership with Evotec... | marketscre... |
23.04.2021 | EVOTEC SE
Evotec : Chairman of the Supervisory Board of Evo... | Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Ann... | marketscre... |
19.04.2021 | EVOTEC SE
Evotec : enters partnership with Kazia Therapeuti... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec enters partnership with Kazia Therapeutics ... | marketscre... |
19.04.2021 | EVOTEC SE
Evotec : enters partnership with Kazia Therapeuti... | Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801
EVOTEC GRANTS K... | marketscre... |
13.04.2021 | Recursion lays out $300M+ goal in IPO terms; Evotec and Br... | Recursion is nearly ready to make its public debut, and the biotech set out what the potentia... | endpts.com... |
13.04.2021 | EVOTEC SE
Evotec : launches 'beLAB2122', translating academ... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
Evotec launches 'beLAB2122', translating academic ... | marketscre... |
13.04.2021 | EVOTEC SE
Evotec : launches “beLAB2122”, translating academ... | Evotec launches 'beLAB2122', translating academic innovation from leading German life science region... | marketscre... |
16.03.2021 | G-CON Manufacturing and Just – Evotec Biologics Complete the... | The arrival of the PODs built and delivered by the exceptional team at G-CON represents another mile... | prweb.com/... |
18.02.2021 | Leading Drug Discovery and Development Company Harmonizes Da... | We have enjoyed a very positive experience [that has] prompted us to deploy Genedata Screener global... | prweb.com/... |
20.08.2020 | Eli Lilly partner AbCellera acquires bispecific plat... | An Eli Lilly partner helping develop a leading Covid-19 project has just scored a new acquis... | endpts.com... |
12.08.2020 | EVOTEC SE
Evotec : reports first half-year 2020 results and... | Evotec SE reports first half-year 2020 results and corporate updates
CONTINUED STRONG PERFORMANCE AC... | marketscre... |
26.05.2020 | EVOTEC SE
EVOTEC : PARTICIPATES IN EXSCIENTIA'S FINANCING R... | DGAP-News: Evotec SE / Key word(s): Miscellaneous
EVOTEC PARTICIPATES IN EXSCIENTIA'S FINANCING ROUN... | marketscre... |
22.04.2020 | EMA approves Boehringer's systemic sclerosis therapy; ... | → The European Commission has approved Boehringer Ingelheim‘s nintedanib for systemic scler... | endpts.com... |
06.04.2020 | Small molecules, biologics and now gene therapies: Ge... | German drug discovery company Evotec — which has a thriving rolodex of biopharma partners s... | endpts.com... |
05.08.2019 | How Biotech Startup Funding Will Change in the Next 10 Years | Back when YC was getting started about 10 years ago, Paul Graham wrote some essays that predicted th... | ycombinato... |
08.07.2019 | Medicxi, Taiho infuse €30M into Evotec spinout — eyeing... | Betting on DNA damage response as the next big frontier in cancer therapies, Evotec is spinn... | endpts.com... |
11.06.2019 | Nasdaq delists Insys after bankruptcy filing; China's... | → On the heels of a bankruptcy filing, Insys announced that it’s getting delisted from the Na... | endpts.com... |
18.04.2019 | Genfit wins BTD status at FDA for its lead drug for liver... | Pascal Birman
→ Genfit $GNFT is getting a helping hand from the FDA with its lead drug elafib... | endpts.com... |
30.08.2018 | Alnylam makes RNAi history again as patisiran gets app... | → Just days after Alnylam landed a historic FDA OK on patisiran — and quickly launched it as ... | endpts.com... |
14.08.2018 | Bayer targets COPD in a new discovery alliance with Hap... | Bayer is adding COPD to its list of discovery targets.
Georg Casari
The German pharma compan... | endpts.com... |
05.10.2017 | SpiroChem ready for further growth | | startuptic... |
04.10.2017 | Dundee-based Exscientia Secures Huge Investment Boost | Exscientia, a Dundee-based research firm which marries AI with drug discovery, has been granted a €1... | digit.fyi/... |